PDF(Pubmed)
Abstract：
Cosmetic filler injections have gained popularity in recent years, but the rise in complications has led to an increase in legal disputes. This study analyzes civil court rulings related to cosmetic filler injection lawsuits in South Korea from 2007 to 2023. A retrospective case analysis was performed using a systematic database search, and a mixed-methods approach was employed for data analysis. The study examined 27 cases, revealing a high rate of liability findings against medical practitioners. Skin necrosis and blindness were the most common complications, and intravascular filler injection was recognized as negligence. Violation of informed consent was found in most cases, with mean compensation awards of ￦193,019,107 KRW ($142,831 USD) for first instance cases and ￦81,845,052 KRW ($60,564 USD) for second instance cases. The findings emphasize the importance of practitioner awareness, adherence to precautionary measures, and proactive prevention and management of complications. Collaboration among stakeholders is crucial for developing strategies that prioritize patient safety and minimize legal disputes in the aesthetic medicine industry. This study provides valuable insights for enhancing medical practices and safeguarding patient well-being in the field of cosmetic filler injections.
摘要：
化妆品填充剂注射近年来越来越受欢迎，但是并发症的增加导致了法律纠纷的增加。本研究分析了2007年至2023年韩国与化妆品填充剂注射诉讼有关的民事法庭裁决。使用系统的数据库搜索进行了回顾性病例分析，采用混合方法进行数据分析。这项研究检查了27例病例，揭示了对医生的高责任率调查结果。皮肤坏死和失明是最常见的并发症，血管内填充剂注射被认为是疏忽。在大多数情况下发现违反知情同意，一审案件的平均赔偿额为193,019,107韩元(142,831美元)，二审案件的平均赔偿额为81,845,052韩元(60,564美元)。研究结果强调了从业者意识的重要性，坚持预防措施，积极预防和管理并发症。利益相关者之间的合作对于制定优先考虑患者安全并最大程度地减少美容医学行业法律纠纷的策略至关重要。这项研究为在化妆品填充剂注射领域加强医疗实践和维护患者福祉提供了有价值的见解。
